Business Description
Advanced Biomed Inc
NAICS : 621512
SIC : 8071
ISIN : US00752P1049
Total Employee Number:
31Description
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 86.77 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -93.7 | |||||
3-Year EPS without NRI Growth Rate | -97.5 | |||||
3-Year FCF Growth Rate | -159.2 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.19 | |||||
9-Day RSI | 60.23 | |||||
14-Day RSI | 56.2 | |||||
3-1 Month Momentum % | -3 | |||||
6-1 Month Momentum % | -26.95 | |||||
12-1 Month Momentum % | -68.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.38 | |||||
Quick Ratio | 7.38 | |||||
Cash Ratio | 1.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 1.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | 90.09 | |||||
ROA % | 62.06 | |||||
ROIC % | -108.09 | |||||
3-Year ROIIC % | 54.42 | |||||
ROC (Joel Greenblatt) % | -603.16 | |||||
ROCE % | -56.28 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1.05 | |||||
PB Ratio | 0.75 | |||||
Price-to-Tangible-Book | 0.76 | |||||
EV-to-EBIT | -1.69 | |||||
EV-to-EBITDA | -1.88 | |||||
EV-to-FCF | -1.93 | |||||
| Price-to-Net-Current-Asset-Value | 0.77 | |||||
| Price-to-Net-Cash | 6.04 | |||||
Earnings Yield (Greenblatt) % | -59.17 | |||||
FCF Yield % | -35.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ADVB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Advanced Biomed Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 4.76 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 61.24 | ||
| 14-Day RSI | 56.2 | ||
| 14-Day ATR ($) | 0.530176 | ||
| 20-Day SMA ($) | 4.549915 | ||
| 12-1 Month Momentum % | -68.48 | ||
| 52-Week Range ($) | 3.61 - 18.2 | ||
| Shares Outstanding (Mil) | 1.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Advanced Biomed Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Advanced Biomed Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings results for 2027 | 2026-11-19 | In 139 days | ||
| Annual report for 2026 | 2026-10-08 | In 97 days | ||
| General meeting for 2025 | 2026-06-30 10:00 | 4.67 (+1.97%) | ||
| Third quarter earnings results for 2026 | 2026-05-15 | 4.43 (-6.54%) | ||
| 0.05:1 Stock Split | 2026-02-20 | 4.53 (+9.10%) | ||
| Second quarter earnings results for 2026 | 2026-02-13 | 4.75 (-5.00%) | ||
| First quarter earnings results for 2026 | 2025-11-19 | 8.27 (+0.15%) | ||
| Annual report for 2025 | 2025-10-08 | 9.52 (+0.23%) | ||
| Third quarter earnings results for 2025 | 2025-05-15 | 23.80 (+0.85%) |
Show
Entries
Advanced Biomed Inc Frequently Asked Questions
What is Advanced Biomed Inc(ADVB)'s stock price today?
The current price of ADVB is $5.07. The 52 week high of ADVB is $18.20 and 52 week low is $3.61.
When is next earnings date of Advanced Biomed Inc(ADVB)?
The next earnings date of Advanced Biomed Inc(ADVB) is 2026-08-15 Est..
Does Advanced Biomed Inc(ADVB) pay dividends? If so, how much?
Advanced Biomed Inc(ADVB) does not pay dividend.
Guru Commentaries on NAS:ADVB
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Advanced Biomed Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers